Many patients already struggle to afford their necessary prescriptions, but the prices of hundreds of drugs — including some generics — are set to rise even higher this year. In a podcast interview with Consultant360, Dr David Nash, founding dean of the Jefferson College of Population Health and chair of the 19th Population Health Colloquium, discusses the patient- and provider-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly address the issue. For more, visit www.consultant360.com.